EU Project Builds Artificial Brain for Robots

Scientists in Spain have achieved a giant leap for robotkind by building the first artificial cerebellum to help them interact with humans. The cerebellum is the portion of the brain that controls motor functions.

The project will now implant the man-made cerebellum into a robot so as to make its movements and interaction with humans more natural. The overall goal is to incorporate the cerebellum into a robot designed by the German Aerospace Centre in two year's time. The researchers hope that their work will also result in clues on how to treat cognitive diseases such as Parkinson's

The four-year project, dubbed Sensopac (SENSOrimotor structuring of perception and action for emerging cognition) is funded by the EU under its Sixth Framework Programme (FP6) and brings together physicists, neuroscientists and electronic engineers from leading universities in Europe.

The scientists at the University of Granada are focusing on the design of microchips that incorporate a full neuronal system, emulating the way the cerebellum interacts with the human nervous system.

Implanting the man-made cerebellum in a robot will allow it to manipulate and interact with other objects with far greater effectiveness than previously managed.

"Although robots are increasingly more important to our society and have more advanced technology, they cannot yet do certain tasks like those carried out by mammals," says Professor Eduardo Ros Vidal, who is coordinating the work at the University of Granada.

"We have been talking about humanoids for years but we do not yet see them on the street or use the unlimited possibilities they offer us," the Professor added.

One possible use for the robots would be as home-helpers for disabled people.

The next step for the Sensopac project will be to develop an artificial skin for the robots, making them look more human-like, as well as making them information-sensitive in the same way as human skin is.

For further information, please visit:
http://www.sensopac.org/index.php?id=27

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...